IES-ACap: Influence of Atrial Pulse Width in the Behaviour of ACap™ Confirm Algorithm. (IES-ACap)
Influence of Atrial Pulse Width in the Behaviour of ACap™ Confirm Algorithm.
Sponsor: Abbott Medical Devices
This observational or N/A phase trial investigates Atrio-ventricular Block and Sinus Bradycardia and is currently completed. Abbott Medical Devices leads this study, which shows 10 recorded versions since 2009 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2023 — Jul 2024 [monthly]
Completed
-
Dec 2022 — Jan 2023 [monthly]
Completed
-
Jan 2021 — Dec 2022 [monthly]
Completed
▶ Show 5 earlier versions
-
Mar 2019 — Jan 2021 [monthly]
Completed
-
Feb 2019 — Mar 2019 [monthly]
Completed
-
Jun 2018 — Feb 2019 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Jan 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Abbott Medical Devices
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.